首頁 > 市場調查報告書 > 醫療設備

醫學影像診斷

市場調查報告書

商品編碼

1588576

全球流體管理監控系統市場 - 2024-2031

Global Fluid Management Monitoring System Market - 2024-2031

出版日期: 2024年11月08日 | 出版商:

DataM Intelligence | 英文 202 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

概述

全球流體管理監控市場在2023年達到19.6億美元，預計到2031年將達到34.3億美元，在2024-2031年預測期間複合年成長率為6.5%。

液體管理過程是醫學中最複雜的領域之一，尤其是在強調每位患者個人需求的住院環境中。在許多情況下，尤其是臥床不起的患者，水合控制的可靠性受到損害，導致高發病率甚至死亡率。因此，液體管理非常重要，因為它可以滿足生理需求，包括流失的液體。

市場動態：

驅動程式和限制

慢性病盛行率上升

由於腎臟病、心臟衰竭、糖尿病等慢性疾病病例的不斷增加，流體管理監測系統的全球市場正在大幅成長。此類疾病需要仔細、準確的監測，以避免併發症並確保積極的結果。透過此類投資，醫療保健提供者正在購買能夠即時提供準確資料的高階系統，以實現及時、更好的最終結果。

隨著人口老化和生活方式趨勢的不斷成長，慢性病在全球舞台上的盛行率不斷增加，對可靠的液體管理控制解決方案的需求預計將會增加，使這些系統能夠支持處理大多數患者的護理複雜性。

例如，根據 Mayo Clinic 2023 的數據，由於公共衛生狀況的改善，傳染病和非傳染性疾病之間的轉變始於 1900 年代初。隨著個人壽命的延長，慢性病盛行率和費用持續上升，預計到 2030 年費用將達到 47 兆美元。

流體管理監控系統成本高昂

全球流體管理監測系統市場也未能倖免於激烈的競爭，這主要是由於成本高昂，特別是在醫院面臨資源和預算限制的發展中地區。這種財務限制阻礙了這些先進設備的大規模實施，即使需要它們來有效管理有液體問題的患者。此外，在資源匱乏的環境中，維護、訓練和軟體升級等成本也限制了該技術的使用。

例如，HysteroLux 流體管理系統控制單元的成本約為 4000-10,000 美元，與其他公司的產品成本一樣高，這阻礙了整個市場在預測期內的成長。

The process of fluid management is one of the most complicated areas in medicine, especially in an inpatient setting that emphasizes the individual needs of each patient. In many instances, especially in patients that are confined to bed, the reliability of the control of hydration is impaired, with resultant high morbidity and even mortality. Fluid management, therefore, is very important because it satisfies the physiological needs, including fluids that are lost.

Market Dynamics: Drivers & Restraints

Rise in the Prevalence of Chronic Diseases

The worldwide marketplace for fluid management monitoring systems is seeing tremendous growth owing to the rising cases of chronic diseases, such as kidney disease, heart failure, diabetes, and others. Such diseases require careful and exact monitoring in order to avoid complications and ensure positive results. With such investments, healthcare providers are purchasing high-end systems that provide accurate data in real-time for timely and better end results.

As the prevalence of chronic diseases increases on the global stage with the growing aging population and lifestyle trends, the need for dependable solutions for fluid management control is projected to increase hence making these systems supportive in dealing with the care complexity of most patients.

For instance, according to Mayo Clinic 2023, the transition between infectious and noncommunicable diseases began in the early 1900s due to improved public health. As individuals live longer, chronic disease prevalence and cost continue to rise, with the estimated cost reaching $47 trillion by 2030. Individual lifestyle, behaviors, and community factors significantly influence the development and management of chronic diseases.

High costs of Fluid Management Monitoring System systems

The global fluid management monitoring systems market is not spared from the stiff competition, mostly due to the high costs involved especially in developing regions where hospitals deal with resource and budget constraints. This financial limit prevents a large-scale implementation of these advanced equipment, even when they are needed for effective management of patients with fluid problems. Also, in low resource environments, the cost of maintenance, training, and software upgrades, etc. limits the access of this technology.

For instance, HysteroLux Fluid Management System Control Unit costs around U$ 4000-10,000 like this other company products cost varies high which hinders the overall market to grow during the forecast period.

Segment Analysis

The global fluid management monitoring system market is segmented based on product type, , application, end user, distribution channel and region.

Fluid management devices segment is expected to dominate the market share

The fluid management devices segment are expected to hold a significant portion of the market share. In healthcare environments such as the operating theatre, the emergency department, and the intensive care unit, fluid management devices play an important role in controlling and measuring patient's fluid saturation levels. They allow for the monitoring of the data in real-time thereby minimizing the chances of over hydration or dehydration of a patient.

The development of technology incorporated solid state devices to allow collection, analysis of data, and easy interaction with EHR'S (Electronic Health Records) enhancing clarity of medical decisions and increasing the recovery chances in patients. Rising occurrences of chronic illnesses, geriatric populace, and less invasive surgical procedures are stimulating the uptake of these devices, making them essential devices in the system for fluid management monitoring market.

For instance, in August 2024, Watson-Marlow Fluid Technology Solutions (WMFTS) has launched WMArchitect, a flexible, single-use solution for biopharmaceutical fluid management. The platform builds on previous products like puresu and asepticsu, aiming to streamline processes, protect products, and reduce regulatory burden.

Geographical Analysis

North America is expected to hold a significant position in the fluid management monitoring system market share

North America is expected to hold a significant position in the global Fluid Management Monitoring System market during the forecast period due to the rapid growth in the geriatric population, the rise in chronic diseases, FDA clearance, the increase in research and development, an increase in technology and many more. Higher living standards and the rise in the number of people suffering from cancer has brought about an increase in demand for fluid administration systems, disposable accessories and also for minimally invasive surgeries.

For instance, in April 2024, Baxter International has received FDA 510(k) clearance for its Novum IQ large volume infusion pump (LVP) with Dose IQ Safety Software. This addition to the Novum IQ Infusion Platform, which includes Baxter's syringe infusion pump (SYR) with Dose IQ Safety Software, allows clinicians to use a single, integrated system across various patient care settings. Baxter's commitment to innovation in infusion therapy is demonstrated by offering the Novum IQ LVP in the U.S.

Moreover, in August 2022, Zynex, a medical technology company, has started enrolling in an ongoing apheresis clinical trial using its second-generation fluid monitoring system, the CM-1600. The study uses the CM-1500 and CM-1600 devices during an apheresis procedure to refine the system's patented Relative Index.

Market Segmentation

By Product Type

Fluid Management Software
Fluid Management Devices

By Application

Surgical Procedures
Cardiovascular Surgery
Orthopedic Surgery
Neurosurgery
General Surgery
Urology Surgery
Critical Care
Pediatric Care
Neonatal Care
Wound Management

By End-User

Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Home Healthcare Providers

By Distribution Channel

Direct Sales
Medical Supply Distributors
Online Sales

By Region

North America
- The U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
South America
- Brazil
- Argentina
- Rest of South America
Asia-Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Middle East and Africa

Competitive Landscape

The major global players in the market include Baxter International Inc., Fresenius Medical Care AG & Co. KGaA, Cardinal Health, Inc., Stryker Corporation,B. Braun Melsungen AG, Medtronic plc, Olympus Corporation, Smiths Medical, Ecolab Inc, KARL STORZ GmbH & Co. KG among others.

Key Developments

In July 2024, Boston Scientific Corporation is considering the sale of its fluid management business, formerly North American Medical Instruments Corp., as part of its ongoing asset review. The business, which produces products for managing fluid and measuring pressure during angiography and angioplasty procedures, is expected to include the company's facilities in Glens Falls, New York and Tullamore, Ireland.

Why Purchase the Report?

To visualize the global fluid management monitoring system market segmentation based on product type, application, end user, distribution channel, and region as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of fluid management monitoring system market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as Excel consisting of key products of all the major players.

The global fluid management monitoring system market report would provide approximately 70 tables, 69 figures, and 202 pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product Type
3.2. Snippet by Application
3.3. Snippet by End User
3.4. Snippet by Distribution Channel
3.5. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Rise in the Prevalence of Chronic Diseases
- 4.1.2. Restraints
  - 4.1.2.1. High Costs of Fluid Management Monitoring System Systems
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Reimbursement Analysis
5.6. Patent Analysis
5.7. SWOT Analysis
5.8. DMI Opinion

6. By Product Type

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 6.1.2. Market Attractiveness Index, By Product Type
6.2. Fluid Management Software*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Fluid Management Devices

7. By Application

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 7.1.2. Market Attractiveness Index, By Application
7.2. Surgical Procedures*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Cardiovascular Surgery
7.4. Orthopedic Surgery
7.5. Neurosurgery
7.6. General Surgery
7.7. Urology Surgery
7.8. Critical Care
7.9. Pediatric Care
7.10. Neonatal Care
7.11. Wound Management

8. By End User

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 8.1.2. Market Attractiveness Index, By End User
8.2. Hospitals*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Ambulatory Surgical Centers
8.4. Specialty Clinics
8.5. Home Healthcare Providers

9. By Distribution Channel

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 9.1.2. Market Attractiveness Index, By Distribution Channel
9.2. Direct Sales*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Medical Supply Distributors
9.4. Online Sales

10. By Region

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
  - 10.2.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  - 10.2.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  - 10.2.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  - 10.2.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.2.3.1. The U.S.
  - 10.2.3.2. Canada
  - 10.2.3.3. Mexico
10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
  - 10.3.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  - 10.3.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  - 10.3.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  - 10.3.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.3.3.1. Germany
  - 10.3.3.2. UK
  - 10.3.3.3. France
  - 10.3.3.4. Italy
  - 10.3.3.5. Spain
  - 10.3.3.6. Rest of Europe
10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
  - 10.4.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  - 10.4.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  - 10.4.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  - 10.4.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.4.3.1. Brazil
  - 10.4.3.2. Argentina
  - 10.4.3.3. Rest of South America
10.5. Asia-Pacific
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
  - 10.5.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  - 10.5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  - 10.5.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  - 10.5.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.5.3.1. China
  - 10.5.3.2. India
  - 10.5.3.3. Japan
  - 10.5.3.4. South Korea
  - 10.5.3.5. Rest of Asia-Pacific
10.6. Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
  - 10.6.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  - 10.6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  - 10.6.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  - 10.6.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel

11. Competitive Landscape

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. Company Profiles

12.1. Baxter International Inc. *
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio and Description
- 12.1.3. Financial Overview
- 12.1.4. Key Developments
12.2. Fresenius Medical Care AG & Co. KGaA
12.3. Cardinal Health, Inc.
12.4. Stryker Corporation
12.5. B. Braun Melsungen AG
12.6. Medtronic plc
12.7. Olympus Corporation
12.8. Smith's Medical
12.9. Ecolab Inc.
12.10. KARL STORZ GmbH & Co. KG

LIST NOT EXHAUSTIVE